Filing Details

Accession Number:
0001415889-24-017532
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-18 21:35:09
Reporting Period:
2024-06-17
Accepted Time:
2024-06-18 21:35:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711968 Leonard Steven Chapman C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-17 1,615 $110.35 217,841 No 4 S Direct
Common Stock Disposition 2024-06-17 3,243 $111.88 214,598 No 4 S Direct
Common Stock Disposition 2024-06-17 1,247 $112.55 213,351 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.02 to $110.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.20 to $112.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.35 to $112.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.